International Journal of Vascular Medicine
Scope & Guideline
Pioneering Research for Cardiovascular Excellence
Introduction
Aims and Scopes
- Clinical Outcomes in Vascular Treatments:
The journal regularly publishes studies evaluating the long-term clinical outcomes of various vascular treatments, including advanced techniques such as endovenous laser treatment and novel anticoagulants. - Pathophysiology and Risk Factors:
Research often explores the underlying mechanisms and risk factors associated with vascular diseases, such as diabetes-related aortic stiffness and hemorrhagic transformation in ischemic stroke. - Innovative Therapies and Technologies:
The journal emphasizes studies on new therapies and technologies, such as diode lasers for vascular malformations, and the impact of lifestyle choices like aerobic exercise on vascular aging. - Public Health and Epidemiology:
Articles frequently address the public health implications of vascular diseases, including the effects of the COVID-19 pandemic on cardiovascular health and the prevalence of microvascular dysfunction in outpatient settings. - Educational Aspects and Practitioner Knowledge:
The journal also highlights the importance of healthcare practitioners' knowledge regarding conditions such as lymphedema, thereby contributing to improved patient care.
Trending and Emerging
- Impact of Lifestyle Choices on Vascular Health:
Recent publications increasingly investigate how lifestyle factors, such as aerobic exercise and the use of electronic cigarettes, affect vascular health, highlighting a growing interest in preventative measures. - COVID-19 Related Vascular Complications:
There is an evident rise in studies addressing the cardiovascular implications of COVID-19, including myocardial injury and the effects of anticoagulants in patients with COVID-19. - Multicenter and International Studies:
The journal is featuring more multicenter and international studies, which enhance the generalizability of findings and reflect a collaborative approach to understanding vascular diseases. - Novel Anticoagulants and Their Clinical Applications:
Research on novel anticoagulants and their potential benefits, particularly in acute limb ischemia, signifies an emerging trend towards innovative therapeutic strategies. - Microvascular Dysfunction and Its Clinical Significance:
The increasing focus on microvascular dysfunction as a significant clinical risk factor indicates a trend towards understanding more nuanced aspects of vascular health.
Declining or Waning
- Traditional Surgical Techniques:
There has been a noticeable reduction in studies focusing on traditional surgical techniques for vascular interventions, as newer, minimally invasive methods gain prominence. - Basic Science Studies:
Research that primarily focuses on basic science without direct clinical applications appears to be waning, as the journal increasingly favors clinical relevance and translational studies. - Longitudinal Studies on Established Risk Factors:
Longitudinal studies that examine well-established risk factors for vascular diseases are becoming less common, with a shift towards more innovative and less explored risk factors.
Similar Journals
MICROVASCULAR RESEARCH
Elevating the Study of Microvascular Function and DiseaseMicrovascular Research is a prominent journal dedicated to advancing the understanding of microvascular biology and its implications in various health and disease contexts. Published by Academic Press Inc elsevier Science, this journal holds a significant place in the academic community with an impact factor reflecting its high citation frequency and relevance within its fields. With a Q2 ranking in both Biochemistry and Cardiology and Cardiovascular Medicine, as well as a Q3 ranking in Cell Biology, it provides an essential platform for researchers and professionals to publish and access groundbreaking studies. Established in 1968 and running through to 2025, Microvascular Research covers a broad scope, focusing on various topics related to microvessels and their functions, emphasizing the importance of these structures in health and pathology. Although the journal does not offer open access, it remains a vital resource for those seeking to deepen their understanding of microvascular dynamics, making it an essential addition to the libraries of researchers, clinicians, and students alike.
Acta Angiologica
Advancing Vascular Health Through Open Access ResearchActa Angiologica, published by VIA MEDICA, is an Open Access journal dedicated to the dynamic field of cardiology and cardiovascular medicine. Since its inception in 1995, this esteemed journal has provided a vital platform for the dissemination of cutting-edge research and innovative medical practices, especially pertinent to vascular health. Being indexed in Scopus, it holds a rank of #352 out of 387 in its category for 2023, positioning it in the 9th percentile among contemporaneous journals. The journal's commitment to scholarly excellence and accessibility is underscored by its embrace of open access publishing, allowing researchers, professionals, and students to engage with vital advancements in the field without financial barriers. With a converged timeline from 2005 to 2024, Acta Angiologica continues to play a crucial role in bridging gaps in cardiovascular knowledge, fostering collaboration across disciplines, and advancing the implementation of preventative and therapeutic strategies in vascular medicine. Located in Gdansk, Poland, the journal is poised to make significant contributions to the cardiovascular research landscape.
Seminars in Vascular Surgery
Elevating surgical excellence through knowledge.Seminars in Vascular Surgery is a premier academic journal dedicated to advancing the field of vascular surgery and related cardiovascular medicine. Published by W B Saunders Co-Elsevier Inc., this journal boasts a commendable reputation within the academic community, evidenced by its classification in the Q1 quartile for both Cardiology and Cardiovascular Medicine and Surgery as of 2023. It serves as a critical resource for researchers, clinicians, and students, providing high-quality, peer-reviewed articles that cover the latest advancements, techniques, and interdisciplinary approaches in vascular surgery. With an ISSN of 0895-7967 and an E-ISSN of 1558-4518, the journal is poised to offer an invaluable platform for scholarship, with a varied scope reflecting decades of research from 1990 to 2024. By submitting your work, you join a cohort of scholars dedicated to elevating the standards of vascular surgical practice and improving patient outcomes.
Artery Research
Fostering collaboration to transform cardiovascular medicine.Artery Research is an esteemed open access journal published by BMC in the United Kingdom, dedicated to advancing the field of vascular biology and cardiovascular medicine. Since its inception in 2006 and transitioning to an open access format in 2019, the journal has become a pivotal platform for disseminating high-quality research on arterial health, pathology, and the latest clinical advancements. With an impactful focus on anatomy, cardiology, and physiology, Artery Research holds a notable reputation within the global research community, ranked in the Q3 and Q4 category quartiles in its respective fields and reflected in its Scopus ranks. The journal aims to foster collaborations and discussions among researchers and practitioners by providing an accessible avenue for publishing pivotal findings and insights. As it continues to evolve through 2024 and beyond, Artery Research remains committed to enriching cardiovascular research and driving innovations toward better health outcomes.
Current Vascular Pharmacology
Advancing Knowledge in Vascular Health and MedicineCurrent Vascular Pharmacology is a premier academic journal published by Bentham Science Publications Ltd, focusing on the intersection of pharmacology and cardiovascular medicine. With an impact factor that reflects its significance in the field, this journal ranks in the Q1 category for both Pharmacology and Cardiology, showcasing its dedication to high-quality research. Its Scopus ranks place it in the top percentile of its categories, highlighting its influence among scholars and practitioners alike. Issued since 2003 and continuing through 2024, Current Vascular Pharmacology aims to disseminate cutting-edge findings and foster knowledge exchange among researchers, professionals, and students engaged in cardiovascular pharmacology. Despite being a subscription-based journal, it remains a vital resource for those seeking the latest advancements in drug development and therapeutic interventions for vascular diseases. Located in the United Arab Emirates, the journal serves as an essential platform for global discourse on vascular health.
International Heart Journal
Connecting Researchers to Enhance Cardiovascular CareInternational Heart Journal, published by INT HEART JOURNAL ASSOC, serves as a pivotal platform for research and discourse in the fields of cardiology and cardiovascular medicine. With its ISSN 1349-2365 and E-ISSN 1349-3299, this esteemed journal is based in Japan and is located at the University of Tokyo, Graduate School of Medicine, Department of Cardiovascular Medicine. Since its inception in 2005, International Heart Journal has blossomed into a respected publication with an impact factor that signifies its growing relevance, ranking in the Q3 category of both cardiology and miscellaneous medicine as of 2023. This journal not only disseminates vital research findings but also fosters collaboration among researchers and healthcare professionals. Notable for its Open Access options, it ensures the availability of its content to a broader audience, thereby enhancing knowledge transfer and innovation in cardiovascular care. With an ongoing commitment to improve clinical practice and patient outcomes, the journal continues to be an essential resource for those dedicated to advancing the understanding of heart health and disease.
ANGIOLOGY
Transforming Cardiovascular Health Through KnowledgeANGIOLOGY is a leading journal dedicated to the field of cardiology and cardiovascular medicine, published by SAGE Publications Inc. With a distinguished history dating back to 1950, this journal serves as an essential platform for the dissemination of cutting-edge research, innovative clinical practices, and emerging trends in cardiovascular health. Holding a respected Q2 ranking in the 2023 Scopus category for Cardiology and Cardiovascular Medicine, and positioned within the 74th percentile of its field, ANGIOLOGY is an invaluable resource for researchers, healthcare professionals, and students alike. While currently not an open-access journal, it offers subscription options to access comprehensive articles that aim to advance knowledge and improve patient care across various cardiovascular disciplines. The journal's commitment to fostering dialogue and sharing groundbreaking findings underscores its importance in the ongoing pursuit of cardiovascular excellence.
International Journal of Angiology
Bridging gaps in angiology through impactful research and dialogue.Welcome to the International Journal of Angiology, a distinguished publication dedicated to advancing the field of cardiology and cardiovascular medicine. Published by THIEME MEDICAL PUBL INC, this journal plays a crucial role in disseminating innovative research and clinical insights from 1992 through 2024, serving as a vital resource for researchers, healthcare professionals, and students alike. With an ISSN of 1061-1711 and an E-ISSN of 1615-5939, the journal currently holds a respectable Q4 ranking in the cardiology field, reflecting its commitment to quality and relevance. Although it operates under a traditional access model, the journal ensures that critical research findings are shared with a broad audience, fostering collaboration and knowledge exchange. By exploring current trends, diagnostic techniques, and treatment modalities in angiology, the International Journal of Angiology remains an essential platform for those dedicated to improving cardiovascular health around the globe.
Stroke and Vascular Neurology
Elevating the standards of vascular neurology.Stroke and Vascular Neurology is a premier open access journal published by BMJ PUBLISHING GROUP, dedicated to advancing the field of vascular neurology and cardiology. With an ISSN of 2059-8688 and an E-ISSN of 2059-8696, the journal has established itself as a leading platform for disseminating cutting-edge research since its transition to open access in 2016. Based in the United Kingdom, at BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND, the journal's outstanding reputation is reflected in its Q1 rankings in both Cardiology and Cardiovascular Medicine and Neurology (clinical) for 2023, placing it in the top tier of its categories. With Scopus rankings of 28 out of 387 in Cardiology and 30 out of 400 in Neurology (clinical), both within the 92nd percentile, Stroke and Vascular Neurology serves as an essential resource for researchers, clinicians, and students looking to stay at the forefront of advancements in the management and understanding of stroke-related disorders. The journal's commitment to high-quality research contributes significantly to improving patient outcomes and shaping the future of vascular health.
JOURNAL OF VASCULAR RESEARCH
Exploring the frontiers of cardiovascular science.Welcome to the JOURNAL OF VASCULAR RESEARCH, a reputable academic journal published by KARGER that has been a cornerstone of vascular research since 1964. With an ISSN of 1018-1172 and an E-ISSN of 1423-0135, this journal plays a vital role in disseminating cutting-edge research in the fields of Cardiology and Cardiovascular Medicine and Physiology. Currently categorized in the Q3 quartile for both disciplines, it ranks as #179 in Cardiology and #131 in Physiology according to Scopus, showcasing its significant contribution to the scientific community. Although the journal operates on a subscription basis, it strives to provide accessible content that informs and inspires researchers, professionals, and students alike. As the journal looks forward to its convergence in 2024, it continues to uphold its mission of advancing knowledge, fostering innovation, and encouraging collaboration within the dynamic realm of vascular research.